Invo Bioscience Stock Current Ratio
| INVODelisted Stock | USD 0.84 0.03 3.45% |
INVO Bioscience fundamentals help investors to digest information that contributes to INVO Bioscience's financial success or failures. It also enables traders to predict the movement of INVO Stock. The fundamental analysis module provides a way to measure INVO Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to INVO Bioscience stock.
INVO |
INVO Bioscience Company Current Ratio Analysis
INVO Bioscience's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current INVO Bioscience Current Ratio | 1.99 X |
Most of INVO Bioscience's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, INVO Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
CompetitionIn accordance with the recently published financial statements, INVO Bioscience has a Current Ratio of 1.99 times. This is 31.62% lower than that of the Health Care Equipment & Supplies sector and 41.47% lower than that of the Health Care industry. The current ratio for all United States stocks is 7.87% higher than that of the company.
INVO Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses INVO Bioscience's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of INVO Bioscience could also be used in its relative valuation, which is a method of valuing INVO Bioscience by comparing valuation metrics of similar companies.INVO Bioscience is currently under evaluation in current ratio category among its peers.
INVO Fundamentals
| Return On Equity | -143.59 | |||
| Return On Asset | -0.27 | |||
| Profit Margin | (1.23) % | |||
| Operating Margin | (1.04) % | |||
| Current Valuation | 15.19 M | |||
| Shares Outstanding | 3.91 M | |||
| Shares Owned By Insiders | 0.60 % | |||
| Shares Owned By Institutions | 3.00 % | |||
| Number Of Shares Shorted | 1.95 K | |||
| Price To Book | 5.97 X | |||
| Price To Sales | 0.56 X | |||
| Revenue | 3.02 M | |||
| Gross Profit | 535.27 K | |||
| EBITDA | (6.63 M) | |||
| Net Income | (8.03 M) | |||
| Cash And Equivalents | 1.96 M | |||
| Cash Per Share | 0.16 X | |||
| Total Debt | 8.68 M | |||
| Debt To Equity | 0.60 % | |||
| Current Ratio | 1.99 X | |||
| Book Value Per Share | (1.59) X | |||
| Cash Flow From Operations | (4.76 M) | |||
| Short Ratio | 0.04 X | |||
| Earnings Per Share | 0.69 X | |||
| Target Price | 20.0 | |||
| Number Of Employees | 25 | |||
| Beta | 1.44 | |||
| Market Capitalization | 3.25 M | |||
| Total Asset | 20.89 M | |||
| Retained Earnings | (57.82 M) | |||
| Working Capital | (6.96 M) | |||
| Net Asset | 20.89 M |
About INVO Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze INVO Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of INVO Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of INVO Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with INVO Bioscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if INVO Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INVO Bioscience will appreciate offsetting losses from the drop in the long position's value.Moving against INVO Stock
| 0.58 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.58 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.41 | DD | Dupont De Nemours Fiscal Year End 4th of February 2025 | PairCorr |
| 0.41 | MMM | 3M Company Fiscal Year End 28th of January 2025 | PairCorr |
| 0.38 | EC | Ecopetrol SA ADR Sell-off Trend | PairCorr |
The ability to find closely correlated positions to INVO Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace INVO Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back INVO Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling INVO Bioscience to buy it.
The correlation of INVO Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as INVO Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if INVO Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for INVO Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in INVO Stock
If you are still planning to invest in INVO Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the INVO Bioscience's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |